Accessibility Statement
This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.
Ketalux is committed to making our content usable for the widest possible audience, including people who use assistive technologies. We aim to conform to WCAG 2.1 Level AA.
What we do
- Semantic HTML, landmarks, and headings for screen-reader navigation.
- Sufficient color contrast and resizable text.
- Descriptive alternative text on informative images.
- Keyboard-accessible navigation and focus styles.
- Plain-language summaries on clinical pages where possible.
Known limitations
Some embedded third-party content (such as research links or external resources) may not fully meet our accessibility standards. We work to provide accessible alternatives where possible.
Report a barrier
If you encounter an accessibility barrier on Ketalux, please email ira@idigits.com with the page URL, the issue, and the assistive technology you use. We aim to respond within five business days.
Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.